Didem Saka
Overview
Explore the profile of Didem Saka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Westphal J, Koch N, Macke L, Vasapolli R, Saka D, Vilchez-Vargas R, et al.
Digestion
. 2025 Feb;
:1-30.
PMID: 39947157
Introduction: Helicobacter pylori is a highly prevalent pathogen affecting approximately 50% of the world population, causing chronic gastritis and subsequently adenocarcinoma. Antibiotic resistance rates in H. pylori are increasing, thus...
2.
Weber S, Erhardt F, Allgeier J, Saka D, Donga N, Neumann J, et al.
Liver Int
. 2025 Feb;
45(3):e70012.
PMID: 39912769
Background And Aims: Drug-induced liver injury (DILI) due to metamizole has gained increasing attention. Causality assessment remains a challenge, especially in patients with co-medications. We therefore aimed to further characterise...
3.
Sirtl S, Hohmann E, Ahmad M, Bretthauer K, Junge M, Vornhulz M, et al.
Pancreatology
. 2024 Aug;
24(6):840-846.
PMID: 39147660
Background: With respect to severity and outcome of an index episode of idiopathic acute pancreatitis the current literature reports conflicting retrospective results. One reason might be the retrospective study design...
4.
Sirtl S, Bretthauer K, Ahmad M, Hohmann E, Schmidt V, Allawadhi P, et al.
Pancreas
. 2024 May;
53(8):e633-e640.
PMID: 38696426
Background/aim: Severity of microlithiasis- and sludge-induced pancreatitis in comparison to gallstone-induced pancreatitis has never been studied for a lack of definition. Materials And Methods: In this retrospective cohort study, 263...
5.
Gundogdu Y, Deniz O, Saka D, Sisman G, Erdamar S, Koksal I
J Oncol Pharm Pract
. 2021 Nov;
28(2):516-518.
PMID: 34791942
Introduction: Sunitinib is a tyrosine kinase inhibitor that binds to vascular endothelial factor receptor currently used for the treatment of renal cell carcinoma, as well as for several other conditions...
6.
Sisman G, Barbur E, Saka D, Erdamar Cetin S
Cancer Immunol Immunother
. 2021 Jan;
70(8):2385-2388.
PMID: 33481043
Advancements in medicine have enabled the use of monoclonal antibodies in the field of oncology. However, the new adverse effects of immunotherapeutic agents are still being reported. We present the...
7.
Sisman G, Barbur E, Saka D, Piyade B, Boynukara C
Endosc Ultrasound
. 2021 Jan;
10(6):474-475.
PMID: 33463557
No abstract available.
8.
Sisman G, Barbur E, Saka D, Piyade B, Besli S, Boynukara C, et al.
Eur J Gastroenterol Hepatol
. 2020 Sep;
32(11):1470-1474.
PMID: 32956180
Objectives: The primary aim of this study was to evaluate the histological adequacy of the liver tissue specimens obtained with a 20-gauge fine-needle biopsy needle and the secondary aim was...
9.
Saka D, Gokalp M, Piyade B, Cevik N, Sever E, Unutmaz D, et al.
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32823814
T-cell exhaustion is a phenomenon that represents the dysfunctional state of T cells in chronic infections and cancer and is closely associated with poor prognosis in many cancers. The endogenous...
10.
Saka D, Sisman G, Ozer L, Sahin D, Ceyhan G
J Gastrointest Cancer
. 2020 Apr;
51(2):722-723.
PMID: 32333250
No abstract available.